Neurons rely on IFNs and autophagy as major defenses against viral infections, and HSV must overcome such defenses in order to replicate. In addition to controlling host immunity, HSV must also control host membranes in order to complete its life cycle. HSV uses the host ESCRT membrane scission machinery for viral production and transport. Here we present evidence of a new IFN-dependent mechanism used by the host to prevent ESCRT subversion by HSV. This activity also impacts the dynamics of autophagy, possibly explaining the presence of recently described LC3 clusters in the HSV-infected nervous system. The induced accumulations of ubiquitin observed in these LC3 clusters resembled those observed in certain neurodegenerative diseases, suggesting possible mechanistic parallels between these conditions.
KEYWORDS: ESCRT, autophagy, herpes simplex virus, interferons, neuroimmunology
ABSTRACT
Interferons (IFNs) and autophagy are critical neuronal defenses against viral infection. IFNs alter neuronal autophagy by promoting the accumulation of IFN-dependent LC3-decorated autophagic structures, termed LC3 clusters. Here, we analyzed LC3 clusters in sensory ganglia following herpes simplex virus 1 (HSV-1) infection. In the vicinity of acutely infected neurons, antigen-negative neurons contained structures resembling accumulated autophagosomes and autolysosomes that culminated in LC3 clusters. This accumulation reflects a delayed completion of autophagy. The endosomal sorting complexes required for transport (ESCRT) machinery participates in autophagosome closure and is also required for HSV-1 replication. In this study, our results showed that HSV-1 infection in vivo and in primary neurons caused a decrease in Vps4 (a key ESCRT pathway ATPase) RNA and protein with concomitant Stat1 activation and LC3 cluster induction. We also observed that IFNs were sufficient to decrease RNA and protein levels of Vps4 in primary neurons and in other cell types. The accumulation of ubiquitin was also observed at the LC3 cluster sites. Together, our results show that IFNs modulate the ESCRT machinery in neurons in response to HSV-1 infections.
INTRODUCTION
Herpes simplex viruses 1 and 2 (HSV-1 and HSV-2) replicate at skin and mucosal sites and invade sensory neurons (1). HSV particles are then retrogradely transported to the cell bodies of these neurons within sensory ganglia, wherein latency is established (1, 2). Latency allows the virus to evade immunity, persist lifelong, and periodically reactivate to spread in the population (1, 2). Latency and immune evasion are keys to the success of the herpesvirus family (3). HSV causes diseases that range from cold sores to more severe outcomes such as keratitis, encephalitis, and chronic pain (4). In addition, the presence of HSV-1 in the central nervous system (CNS) has been associated with neurodegenerative diseases (5).
Interferons (IFNs) and autophagy are key neuronal defenses against HSV-1 (6–8). Upon HSV-1 infection, neurons secrete and respond to type I IFNs (9), which activate the JAK-STAT pathway (10) and promote antiviral IFN-stimulated gene (ISG) expression (11). Macroautophagy (here autophagy) is important for the elimination of microorganisms (12). In brief, autophagy begins when cytosolic material is engulfed into double-walled autophagosomes, which fuse with lysosomes to form autolysosomes. Contents are then degraded by lysosomal enzymes (13). Neuronal autophagy is critical for development, differentiation, clearance of misfolded proteins, and pathogen defense (14). Importantly, type I IFN and autophagy are connected: type I IFN increases autophagy rates (15) and autophagy is required for type I IFN activation (16). IFN-γ is the only member of the type II IFNs. IFN-γ activates the JAK-STAT pathway in a different manner than type I IFNs, resulting in the transcription of type I IFN-overlapping and nonoverlapping ISGs (11). IFN-γ increases levels of autophagy during the antiviral response (17, 18), and autophagy is essential for antigen presentation and the development of the adaptive immune response (16).
A key pathway for both virus infectivity and host response is the endosomal sorting complexes required for transport (ESCRT) machinery. ESCRT promotes budding and partitioning of membranes during vesicle formation through reverse topology membrane scission, in which the cytosolic contents remain within the lumen of the vesicle (19). There are 5 ESCRT subgroups. ESCRT-0, ESCRT-I, and ESCRT-II complexes coordinate ESCRT assembly, membrane deformation, and cargo sorting. ESCRT-III and the vacuolar protein sorting 4 (VPS4) complexes catalyze membrane fission and ESCRT disassembly (20). ESCRT-III and VPS4 mediate the closure of autophagosomes, in vitro and in vivo (21–23). Many enveloped viruses require ESCRT machinery components for viral budding. HIV-1 subverts ESCRT-III/VPS4 machinery (23), and HSV-1 uses VPS4 and ESCRT-III for viral production, transport, envelopment, and nuclear egress (24–28).
HSV infection and IFN activation induce LC3-decorated autophagic structures in sensory neurons known as LC3 clusters (29). In this study, we characterized kinetics of LC3 clusters, IFN activation, and completion of autophagy in HSV-1-infected trigeminal ganglia (TG). We determined that LC3 clusters are structures resembling accumulations of autophagosomes and oversized autolysosomes in vivo. Given the similarities of LC3 clusters to accumulated autophagosomes in ESCRT-III/VPS4-deficient models (22, 30), we tested the hypothesis that IFNs control HSV-1 infection through Vps4 and other ESCRT pathway members. Vps4 RNA and protein levels were decreased in TG of HSV-infected mice, congruent with the presence of LC3 clusters and Stat1 activation. Using primary adult mouse TG neurons, we showed reduced Vps4 in HSV-1 antigen-negative neurons within infected cultures. We also showed that IFNs are sufficient to induce a decrease in RNA and protein levels of Vps4 and to alter ESCRT-III proteins. Decreased protein levels of Vps4 upon IFN stimulation were also observed in fibroblasts. Finally, we observed that LC3 clusters in primary cultures were proximal to areas of high levels of ubiquitin. Taken together, these results show that IFN-induced alterations of the ESCRT machinery in neurons likely act as a defense against HSV-1 infection.
RESULTS
LC3 clusters in vivo likely result from stalled IFN-induced autophagy.
LC3 clusters accumulate mainly in neurons in proximity to HSV-infected neurons (29). To establish the kinetics of these clusters, we used LC3-GFP+/− mice in which LC3 is fused to GFP (31, 32). Transgenic cells display a cytoplasmic GFP haze, but autophagosome-bound GFP-LC3 manifests as distinct GFP puncta (0.5 to 1 μm), indicative of autophagy (29). We have defined LC3 clusters as accumulations of LC3-GFP of >2 μm2. LC3-GFP+/− mice were infected with HSV-1 and analyzed for LC3 clusters and HSV-1 antigen expression (Fig. 1A). Mock-infected sections showed only sporadic LC3 clusters. At 3 days postinfection (dpi), HSV-1 antigen was detected in ophthalmic TG neurons and 15% of neurons were LC3 cluster positive (Fig. 1A). At 6 dpi, HSV-1 antigen detection was minimal but LC3 clusters increased up to 35% of ophthalmic branch neurons. At 12 dpi, HSV-1 antigens were absent and LC3 clusters were detected in <10% of neurons but remained significantly above mock-infected levels. LC3 cluster total fluorescent area mimicked this temporal pattern, averaging 4 µm2 at 3 dpi and 8 µm2 at 6 dpi and diminishing to 6 µm2 at 12 dpi (Fig. 1A).
LC3 cluster-positive neurons observed in Fig. 1A were HSV-1 antigen negative, in agreement with our previous report (29). However, some of the antigen-negative neurons could be HSV-1-infected neurons that are below the threshold of detection by immunofluorescence. To test whether LC3 clusters may occur in infected neurons, we performed corneal infection using HSV-1 strain McKrae. McKrae is more neuroinvasive than strain 17, facilitating HSV-1 detection. As seen with strain 17, LC3 cluster-positive neurons were almost entirely antigen negative 3 dpi with McKrae (Fig. 1B, white arrowheads). However, we were able to find occasional LC3 clusters in HSV-1-positive neurons (Fig. 1B, blue arrowheads). This result confirms that LC3 clusters are formed mainly in antigen-negative neurons but that HSV-1 antigens and LC3 clusters occasionally coexist in neurons.
Protein extracts from infected LC3-GFP+/− mouse TGs were analyzed by Western blotting (WB) to track IFN pathway and autophagy activation and completion. Bulk TG extracts from LC3-GFP+/− mice represent mainly noninfected tissue, since <2% of TG neurons innervate the cornea (33) and the C57/BL6 mouse background is relatively resistant to HSV infection (34, 35). Stat1 is activated by phosphorylation at tyrosine 701 (referred to here as p-Stat1) following IFN stimulation. TG p-Stat1 levels were significantly elevated 3 dpi, in agreement with type I IFN expression kinetics (36) (Fig. 1C). p-Stat1 peaked at 6 dpi, concomitant with the expected migration and activation of CD4+ and CD8+ cells and presence of IFN-γ in the infected TG (37). By 12 dpi, p-Stat1 had returned to background levels (Fig. 1C). We also measured protein levels of Stat1, which, as expected (11), were increased at 6 dpi and remained elevated at 12 dpi (Fig. 1C). Interferon-stimulated gene 15 (Isg15), a downstream effector of Stat1 signaling, showed a similar pattern as p-Stat1 but with a slightly earlier peak (Fig. 1C). To track autophagy, we measured activation/phosphorylation of the key autophagy protein Beclin-1 (38) on threonine 117 (p-Beclin-1) which activates it in a death-associated protein kinase (DAPK)- and IFN-dependent manner (17, 18). As expected, mock extracts showed significant p-Beclin-1, consistent with a high basal autophagy in neurons (39). At 3 dpi, p-Beclin-1 levels increased but unexpectedly dropped to levels below that of mock-infected cells at 6 and 12 dpi (Fig. 1C). We also measured protein levels of Beclin-1 which were steady state out until 12 dpi, at which point they were significantly increased (Fig. 1C). Finally, we analyzed autophagosome maturation by measuring levels of the autophagy adaptor protein P62, which decreases as autophagy is completed (40). P62 levels were comparable to mock-infected TG 3 dpi but were then significantly decreased at 6 and 12 dpi (Fig. 1C). At 12 dpi, a change in the band patterning of P62 was also observed; the lower band appeared stronger than the upper band, consistent with changes in P62 phosphorylation (41). Together, these results showed that LC3 clusters are transient structures that are proximal to, but not coincident with, infected HSV-1 neurons. We also observed a biphasic autophagic response with increases in p-Beclin-1 at 3 dpi while maturation of autophagy (P62 reduction) was delayed until6 to 12 dpi. The pattern of p-Beclin-1, Beclin-1, and P62 kinetics supports the hypothesis that LC3 clusters result from IFN-induced stalled autophagy.
LC3 clusters in vivo are consistent with accumulated autophagosomes and autolysosomes.
To further examine LC3 clusters in vivo, we performed high-resolution (AiryScan; Zeiss) confocal microscopy on TG sections from infected LC3-GFP+/− mice at 6 dpi (Fig. 2A). LC3 clusters had two distinct morphologies. Some clusters appeared as accumulated GFP spheroids (closed or open) with sizes from 0.5 to 1 μm, compatible with autophagosomes and phagophores (Fig. 2A, upper panels). Other clusters appeared as irregular oversized spheres (>1 μm) (Fig. 2A, lower panels), consistent with aggregations of large autolysosomes resulting from lysosomal fusion with autophagosomes. To test these hypotheses, we probed TG sections for the lysosome marker Lamp1 by immunofluorescence (Fig. 2B). More than half of the LC3 clusters showed weak costaining with Lamp1, consistent with the hypothesis that these clusters are accumulated, early autolysosomes (Fig. 2B, white arrowhead). As expected, the remaining LC3 clusters showed strong costaining with Lamp1, suggesting that these clusters are more mature autolysosomes (Fig. 2B, magenta arrowhead). These results demonstrate that LC3 clusters in vivo show structures similar to accumulated autophagosomes and oversized autolysosomes.
Vps4 is decreased in HSV-1-infected TG.
The precise mechanism of autophagosome closure remains obscure, but it seems likely that ESCRT-III and VPS4 complexes participate (42). In a variety of systems, modulation of ESCRT-III members (especially CHMP2B and 4B) and VPS4 results in autophagosome accumulation in neurons and other cells (21, 22, 30). Intriguingly, reduction of ESCRT-III and VPS4 activity also limits HSV-1 replication (24–28). This led us to hypothesize that IFNs may decrease ESCRT-III and/or Vps4 and stimulate neuronal antiviral defense. This decrease of ESCRT-III and/or Vps4 would also limit completion of autophagy, resulting in accumulation of autophagic structures and LC3 clusters. To test this hypothesis, we performed WB on protein extracts from TG of HSV-1-infected mice probing for Chmp2B and Chmp4B (Fig. 3A) and Vps4 (Fig. 3B). The core protein Chmp4B did not change significantly, but Chmp2B levels increased out to 12 dpi (Fig. 3A). In mammalian cells, the Vps4 complex is formed by oligomerization of two independent paralogues, Vps4A and Vps4B (43, 44). Vps4A and Vps4B share ∼80% amino acid sequence homology. We used an antibody capable of recognizing both isoforms. Surprisingly, Vps4 was significantly decreased at 3 dpi and 6 dpi but was comparable to mock levels at 12 dpi (Fig. 3B). These results show that Vps4, a key component of the autophagosome closure machinery, was decreased with comparable kinetics to phosphorylation of Stat1 (Fig. 1B) and presence of LC3 clusters (Fig. 1A).
HSV-1 antigen-negative neurons show low levels of Vps4 in infected TG primary culture.
In vivo, we observed a marked decrease of Vps4 levels in HSV-1-infected TG, yet relatively few TG neurons are infected with HSV following corneal challenge (33). It seems most likely, therefore, that our observed decrease in Vps4 resulted from a paracrine IFN-dependent antiviral response. To address this, we cultured primary adult mouse TG neurons, infected them with HSV-1 at MOIs of 5 and 25, and performed WB analysis for Vps4 and Stat1 (Fig. 4A). Consistent with the in vivo data, at both MOIs, levels of Vps4 were decreased and levels of p-Stat1 were increased in HSV-1-infected neuronal cultures. Although Vps4 protein levels were decreased, we were concerned that this could be due to HSV-1 induction of host shutoff cellular protein synthesis (45). We therefore performed an immunofluorescence (IF) assay to analyze Vps4 modulation in infected and noninfected neurons (Fig. 4B). In uninfected neuronal cultures, Vps4 staining was strong, diffuse, and homogeneous, and all neurons showed similar levels of Vps4 (Fig. 4B, upper panels). We infected TG neurons at an MOI of 25. At this MOI, all neurons were likely infected, but infections progressed efficiently in some neurons (antigen positive) while infection was not detected in others (antigen negative). In infected cultures, Vps4 staining was significantly altered, showing an uneven pattern (Fig. 4B, lower panels). MFI analysis showed strong Vps4 fluorescence in neurons that were HSV antigen positive in these infected cultures (Fig. 4, graph). In contrast, in HSV-1 antigen-negative neurons, Vps4 staining was decreased compared to antigen-positive neurons (Fig. 4B, lower panels, white arrowhead). Since decreased Vps4 corresponded with LC3 clusters, this result is consistent with the presence of LC3 clusters in HSV-1 antigen-negative neurons (29). Interestingly, reduced Vps4 was observed in almost all HSV-1 antigen-negative neurons, regardless of LC3 clusters (data not shown). Together, these results support the notion that decreased Vps4 is a component of an antiviral response that is coincident with increased levels of p-Stat1.
IFNs are sufficient to decrease Vps4 protein levels in primary TG cultures and in other cell types.
Our results showed an inverse relationship between levels of p-Stat1 and Vps4. In a previous report, we demonstrated that LC3 clusters were formed when neurons were treated with exogenous IFN-β (29). These LC3 clusters induced by IFN-β in culture peaked at 12 to 24 h posttreatment and decreased rapidly thereafter. In vivo, in contrast, LC3 clusters remained stable for several days, suggesting that there may be an additional factor which sustains or stabilizes LC3 clusters (Fig. 1). We hypothesized that IFN-γ may be this factor. In order to more closely mimic the in vivo situation, we stimulated neurons in primary culture with a combination of 100 IU/ml of IFN-β plus 50 IU/ml of IFN-γ (IFN β+γ) or with 100 IU/ml of IFN-β. In nontreated neurons, LC3 clusters were rarely found at any time tested (Fig. 5A, graph). After IFN-β treatment for 1 day, ∼25% of neurons were LC3 cluster positive (Fig. 5A, graph), and similar levels were found when neurons were stimulated with IFN β+γ (Fig. 5A, graph and left panels). As expected, levels of LC3 clusters dropped to basal levels following IFN-β treatment for 4 days (Fig. 5A, graph). In contrast, treatment with IFN β+γ resulted in a sustained increase in numbers of LC3 cluster-positive neurons relative to those treated with IFN β+γ for 1 day (Fig. 5A, graph and right panels). IFN β+γ treatment of TG neurons therefore recapitulates the sustained presence of LC3 clusters in vivo. We then analyzed these TG neurons by WB for Vps4 (Fig. 5B). Vps4 protein levels were decreased after 1 and 4 days of treatment with IFN β+γ compared to nontreated neurons (Fig. 5B). These results confirmed that IFNs reduced Vps4 protein levels. We probed for p-Stat1, which, as expected, was present in IFN β+γ-treated neurons at all time points tested (Fig. 5B), while protein levels of Chmp4b and Chmp2B were unchanged (data not shown).
We next examined TG primary neurons by IF for Vps4 upon IFN β+γ treatment for 4 days. While untreated neurons showed a strong, diffuse, and homogeneous Vps4 staining (Fig. 5C, left panels), treatment with IFN β+γ resulted in a general decrease of Vps4 staining (Fig. 5C, right panels). Three distinct patterns emerged: neurons negative for LC3 clusters with a strong Vps4 staining (Fig. 5C, right panels, yellow arrowhead), neurons negative for LC3 clusters with weak Vps4 staining (Fig. 5C, right panels, white arrowhead), and neurons positive for LC3 clusters with weak Vps4 staining (Fig. 5C, right panels, green arrowhead). It was noteworthy that all LC3 cluster-positive cells showed weak Vps4 staining. That said, not all Vps4-weak neurons were LC3 cluster positive. This suggests that TG neurons do not respond equally to IFN, which is expected since these neurons are heterogeneous (46). Finally, we wished to address whether the IFN-induced decrease of Vps4 is a neuron-specific response or represents a more broad-spectrum antiviral response. To test this, we treated a variety of primary cell types with IFN β+γ. Adult mouse TG-derived glia and fibroblasts did not show any change in Vps4 protein levels upon IFN β+γ treatment (data not shown). In contrast, IFN β+γ-treated adult mouse primary fibroblasts showed strong decreases in protein levels of Vps4 (Fig. 5D), although LC3 clusters were not detected in these cells (data not shown). These results show that treatment with IFN β+γ induced stable LC3 clusters and decreased Vps4 levels in TG neurons. Decreased Vps4 was also observed in fibroblasts in the absence of LC3 clusters.
IFNs are sufficient to decrease Vps4A and Vps4B RNA levels in primary TG cultures.
We further analyzed changes in Vps4 observed in TGs of HSV-1-infected animals by real-time qPCR analysis of Vps4 expression. Vps4A and Vps4B differ in their 5′ UTR at the mRNA level, allowing independent analysis of both genes. We isolated mRNA from TG of mice corneally infected with HSV-1 and found that Vps4A RNA levels were unchanged at 3 dpi, significantly decreased at 6 dpi, and comparable to mock levels at 12 dpi (Fig. 6A, upper left). In contrast, Vps4B RNA levels followed a similar pattern as Vps4A (Fig. 6A, upper right). We also analyzed RNA levels of ESCRT-III genes known to be involved in neuronal autophagy (Fig. 6A, lower left). Chmp4B RNA was unchanged during the course of the infection, while Chmp2B mRNA was significantly increased at 12 dpi (Fig. 6A, lower middle). This is in agreement with increased Chmp2B protein at the same time point (Fig. 3A). As an internal control, we monitored mRNA levels of Isg15 (Fig. 6A, lower right), consistent with the protein data (Fig. 1B). We confirmed these data by using mRNA from adult TG neurons treated with IFNs. There were no changes in RNA levels of Vps4A in IFN β+γ–treated TG neurons on day 1 (Fig. 6B, left upper), but Vps4B RNA was significantly decreased (Fig. 6B, upper middle). After 4 days of IFN β+γ treatment, RNA levels of both Vps4A and Vps4B were substantially decreased (Fig. 6B, lower left and lower middle, respectively). As a positive control, we observed expected significant increases in Isg15 RNA 1 and 4 days post-IFN β+γ treatment (Fig. 6B, upper right and lower right, respectively). These results show that IFNs can cause significant decreases in Vps4A and Vps4B RNA levels.
IFNs alter Chmp4B in TG primary culture.
ESCRT-III proteins, such as Chmp4B, remain soluble and monomeric prior to activation. When recruited, these proteins polymerize and form filaments that are key to membrane scission. The ATPase complex Vps4 provides energy during the last steps of membrane scission and allows depolymerization and recycling of ESCRT-III proteins (20). In addition, overexpression of ISG15 alters several ESCRT-III proteins, like CHMP4B, and ISGylation blocks their interaction with VPS4 (47, 48). Together, these data make it plausible that IFNs affect ESCRT-III protein activity in TG neurons. To test this, we treated mouse adult TG neurons with IFN β+γ and stained them for Chmp4B (Fig. 7). In nontreated TG neurons, Chmp4B was largely homogeneous (Fig. 7, upper panels), as expected for a soluble cytoplasmic protein (49). In IFN β+γ-treated neurons, however, we observed that ∼50% of the neurons exhibited accumulations of Chmp4B or “Chmp4B puncta” (Fig. 7, graph). Chmp4B puncta were not associated with LC3 clusters in some neurons (Fig. 7, middle panels), were observed in LC3 cluster-negative neurons (data not shown), and were in close proximity to LC3 clusters in other neurons (Fig. 7, lower panels). This is consistent with the hypothesis that Chmp4B puncta represent accumulated Chmp4B filaments within membranes of autophagic structures and other membrane-bound vesicles, as a result of limiting levels of Vps4.
LC3 clusters contain ubiquitin in IFN-treated TG neurons.
Transgenic Drosophila flies which overexpress dominant negative VPS4 show ubiquitin colocalized with LC3 cluster-like aggregates in the brain (22). Ubiquitinylation is a process involved in autophagy by which proteins and organelles are selectively tagged for degradation (13). If IFN delays the completion of autophagy, then LC3 clusters should colocalize with an accumulation of ubiquitin. To test this hypothesis, we examined the contents of LC3 clusters by IF microscopy using the P4D1 monoclonal antibody, which recognizes ubiquitin and polyubiquitinated and ubiquitinated proteins. By regular microscopy, we observed that following IFN β+γ treatment, all LC3 clusters were colocalized with ubiquitin (Fig. 8A). High-resolution (AiryScan; Zeiss) confocal microscopy showed that ubiquitinated proteins accumulated either inside or surrounding the LC3 clusters (Fig. 8B). These data suggest that LC3 clusters contain cellular material which is either undigested or about to be digested. These results demonstrated that LC3 clusters occur in close proximity to ubiquitin accumulation, comparable to the pattern observed in VPS4 dominant negative transgenic Drosophila (22). These data have important implications, as discussed below, for the functional significance of LC3 clusters.
DISCUSSION
Herpesviruses and their host cells compete for the control of internal membranes in infected cells. ESCRTs are a group of proteins which regulate reverse topology membrane scission and are involved in many functions, including the formation of multivesicular endosomes and autophagosomes, among other functions (50). Due to their ability to reorganize internal membranes, many viruses commandeer ESCRT components during viral replication (23). In particular, HSV-1 uses VPS4 and several ESCRT-III proteins to rearrange cellular membranes for replication (24–28). In this study, we have presented evidence that IFNs modulate the ESCRT machinery in response to HSV-1 infection. Our results show that, upon HSV-1 corneal infection, levels of Vps4 are significantly decreased in the TG, in parallel with p-Stat1 activation and expression of Isg15. Additionally, in primary culture, IFN treatment reduces levels of Vps4 in adult TG sensory neurons. Therefore, reduction of Vps4 by IFN alters ESCRT-III protein function. Overexpressing dominant negative VPS4 is efficient in limiting HSV-1 production (24, 26, 27), consistent with the idea that host defenses utilize a similar antiviral strategy.
One of the functions of IFNs is to maintain control of host membranes upon infection (11). To do so, IFNs stimulate production of several membrane-modulating ISGs, such as tetherin, viperin, and IFITM (11). In addition, IFNs regulate ESCRT-III function through ISG15 (47, 48), a small molecule which acts in an ubiquitin-like manner (51) with strong antiviral properties against HSV and other viruses (52). Several CHMPs, including CHMP4B, can be covalently bound to ISG15 (47, 48). Upon conjugation, the ability of CHMPs to interact with VPS4 is reduced, thereby slowing the system and reducing its utility for viruses (47, 48). In these previous studies, however, ISG15 was associated with CHMPs and not with VPS4 (47, 48). Our finding that IFNs directly regulate Vps4 in neurons and in other cell types therefore adds a new and complementary layer of control of ESCRT machinery by IFNs. ISG15 conjugation was recently shown to be a broad nonspecific mechanism to destabilize newly synthesized viral proteins (53, 54). It is possible therefore that IFNs control the ESCRT machinery in two different ways, first in a nonspecific manner through ISG15 and second in a more ESCRT-specific manner by reducing levels of Vps4. In support of this hypothesis, we have recently observed that LC3 clusters are still present in the TG of HSV-1-infected Isg15-deficient mice (data not shown).
An important open question is how IFNs regulate Vps4. IFNs lead to Stat1 phosphorylation, translocation into the nucleus, and binding to DNA, promoting the transcription of ISGs (10, 11). However, some genes are repressed as a consequence of transcriptional changes mediated by Stat1 (55, 56), and this may be the case for Vps4A and Vps4B. Our results show that IFN treatment leads to decreased Vps4 RNA and protein. Vps4A and Vps4B are positionally conserved among mammals, consistent with the idea that their genomic position may be important for the control of their expression. Indeed, the Vps4A gene is close to a conserved Stat1 binding site (57, 58). We hypothesize that increased transcription of genes surrounding Vps4A upon IFN activation may interfere with Vps4A transcription. Vps4B is in the vicinity of the antiapoptotic gene Bcl-2 (58), which is highly regulated by Stat1 and IFNs (59–61), and a similar mechanism may explain the IFN-induced decrease of Vps4B mRNA. Studies are ongoing to better understand the regulation of these important genes by IFN.
The initial goal of this study was to determine the molecular basis of neuronal LC3 cluster formation upon IFN stimulation (29). IFNs increase levels of autophagy (15, 16), and autophagy/xenophagy is a key antiviral defense in neurons against HSV-1 (7, 8, 29). As expected, some autophagy markers were increased rapidly upon HSV-1 infection of the TG with strong LC3 accumulation and increased levels of p-Beclin-1. However, the maturation of autophagosomes as measured by the degradation of P62 did not occur until 6 dpi. Vps4 and ESCRT-III regulate the closure of autophagosomes, and IFNs may therefore modulate autophagy in two different ways (21, 22, 30). First, it may increase levels of upstream autophagy. Second, it may reduce levels of Vps4 and reduce Chmp activity by ISGylation, thereby slowing the closure of autophagosomes. These data fit with the strong association of ubiquitin with LC3 clusters, which would mark undigested or soon-to-be digested cargo. We thus propose that LC3 clusters in neurons are the result of IFN-induced autophagy that is delayed in its maturation. This hypothesis presents LC3 clusters as a passive by-product of two activities, IFN-induced autophagy and IFN-induced decrease of Vps4. While we favor this hypothesis, it is also possible that LC3 clusters have a more active function. Since neurons have high levels of basal autophagy, increasing those levels further could jeopardize neuronal integrity and result in autophagic cell death (39). Slowing the completion of autophagy would be a safe manner to control the IFN-induced increase of autophagy. Another possibility is that LC3 clusters may be reservoirs for MHC-I loading. Neurons are polarized and immune-privileged cells, and unstimulated neurons do not express detectable levels of MHC-I. The IFN response to HSV-1 infection, however, induces both LC3 clusters (29) and increased levels of MHC-I in sensory neurons (62). It is plausible that LC3 clusters may accumulate proteins from distal sources in the neuron to digest them and facilitate the loading of peptides into MHC-I.
Finally, some authors have proposed that HSV-1 infections are associated with, and may even be causal to, neurodegenerative diseases (5, 63–65). Curiously, some mutations in autophagy-related genes and in the ESCRT-III protein CHMP2B lead to neurodegenerative diseases with accumulation of ubiquitin (66–69). Here, we present evidence showing that HSV-1-induced IFN decreases Vps4 and alters ESCRT-III activity, causing a delayed completion of autophagy and accumulation of ubiquitin. These changes appeared to be transient and associated with HSV-1 productive infection. HSV-induced LC3 clusters, however, resemble some neurodegenerative markers (14, 30). These similarities may fuel further speculation regarding the interplay of HSV-1 chronicity and degenerative diseases of the human central nervous system (5).
MATERIALS AND METHODS
Viruses and animals.
The wild-type HSV-1 strain 17 syn+ (GenBank accession no. NC_001806) and the wild-type HSV-1 strain McKrae (GenBank accession no. JX142173) (70) were propagated and plaqued on Vero cells using standard practices, as previously described (71).
Noboru Mizushima provided green fluorescent protein (GFP)-LC3 mice (31, 32). To maintain the colony of GFP-LC3 +/− mice, these were crossed with C57BL/6J mice purchased from Jackson Laboratories and bred in-house.
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Research Council (72). The protocol was approved by the Dartmouth IACUC (permit number leib.da.1#2m13a). No surgery was performed, and all efforts were made to minimize suffering.
Culture of adult mouse TG neurons.
TG neurons from adult mice were isolated and cultured as previously reported (73). Twelve-millimeter coverslips (for IF) or M24 wells (for WB) were coated with poly-d-lysine (BD Biosciences) at 100 μg/ml in Hanks balanced salt solution lacking calcium and magnesium (HBSS; HyClone) overnight. Surfaces were then washed three times with HBSS and coated with natural mouse laminin (Invitrogen) at a concentration of 18 μg/ml in HBSS overnight. TG neurons were isolated as described previously, with a few modifications (73). Mice 5 to 10 weeks old were euthanized using approved methods and transcardially perfused with phosphate-buffered saline (PBS; HyClone). TG were harvested and enzymatically digested in a solution consisting of 40 U/ml of papain (Worthington) in HBSS with 2.75 mM l-cysteine (Sigma) and 8% NaHCO3 diluted 1:1,000 (Sigma) for 20 min at 37°C on a rotator. This was followed by a similar incubation in a solution of 5 mg/ml of collagenase type II (Invitrogen) and 5.5 mg/ml of neutral protease (Worthington) dissolved in HBSS. TG were then triturated in Neurobasal-A (NB-A) working medium (Neurobasal-A (Invitrogen), 2% B27 (StemCell), and 1% penicillin-streptomycin (Pen-Strep; HyClone). The resulting homogenate was spun over a two-layer density gradient made with Percoll and NB-A working medium. Neurons were pelleted by a 10-min centrifugation at 1,300 × g, upper layers were discarded, and the pellet was washed three times in NB-A working medium. Neurons were resuspended in minimal volumes of NB-A complete medium, including the antimitotic 5-fluoro-2-deoxyuridine (FUDR; Sigma) for a minimum of 3 days prior to use. NB-A complete medium consisted of Neurobasal-A, 2% B27, 1% GlutaMAX (Invitrogen), 1% Pen-Strep, 50 ng/ml of nerve growth factor (NGF; Invitrogen), 50 ng/ml of glial cell-derived neurotrophic factor (GDNF; R&D Systems), and 50 ng/ml of Neurturin (R&D Systems). Three thousand six hundred neurons were seeded per 12-mm glass slide or M24 well and were grown for 2 or 3 days before treatments or infections.
Ear-derived fibroblast isolation and culture.
Fibroblasts from adult mice were obtained through ear clippings and subsequently minced and digested in 1,000 U/ml collagenase type II (Invitrogen) followed by 0.05% trypsin (Cellgro). Resulting cell lysate was triturated and plated in 6-well plates in DMEM (HyClone) with 10% FBS, 1% nonessential amino acids, 1% GlutaMAX (Invitrogen), and 1% Pen-Strep.
Treatments.
Mouse adult TG neurons and mouse adult ear-derived fibroblasts were treated with 100 U/ml of mouse IFN-β (PBL Interferon Source) and 50 U/ml of mouse IFN-γ (Miltenyi Biotec) or with 100 U/ml of mouse IFN-β (PBL Interferon Source) for the time indicated.
HSV-1 infections. (i) In vivo.
Mice were anesthetized intraperitoneally with ketamine (90 mg/kg of body weight) and xylazine (10 mg/kg). Corneas were bilaterally scarified with a 25-gauge syringe needle, and virus was inoculated by adding 1 × 106 PFU per eye in a 3-μl volume. To reduce pain caused at the cornea, mice were then injected with buprenorphine (0.41 mg/kg).
(ii) In vitro.
Infections of TG primary cultures were performed at MOIs of 5 and 25 for 48 h. Cultures were incubated with the virus for 1 h to allow viral adsorption, and then medium was replaced.
Western blots.
Extracts were prepared by homogenizing TG in ice-cold extraction buffer consisting of 20 mM HEPES, pH 7.4, 150 mM NaCl, 1% Triton X-100, cOmplete protease inhibitor cocktail tablets (Roche), and PhosStop phosphatase inhibitor cocktail (Roche). Samples were homogenized and centrifuged at 15,000 × g for 15 min at 4°C. The resulting supernatant was collected, and protein content was determined by Bradford assay. Ten to 30 micrograms of total protein was electrophoresed on an SDS-polyacrylamide gel (concentration ranged between 8% and 15% depending on size of the protein analyzed), transferred to a PVDF membrane, and blocked in PBS-T with 5% nonfat dry milk. Primary antibodies were incubated overnight. Membranes were developed using SuperSignal West Dura extended-duration substrate (Thermo Fisher Scientific) using an Alpha Innotech FluorChem Q imager. Every WB was stripped using Restore (Thermo Fisher Scientific) and rehybridized against β-actin for normalization.
Antibodies. (i) IF.
Rabbit polyclonal anti-HSV-1 was purchased from Dako. Chicken anti-β3-tubulin was obtained from Millipore. Mouse monoclonal CHMP4B antibody (clone 13G12) was from Covalab. Antibodies against Lamp1 (clone 1D4B), VPS4 (clone E8), and ubiquitin and polyubiquitinated and ubiquitinated proteins (clone P4D1) were from Santa Cruz Biotechnology.
Secondary antibodies, all Alexa Fluor conjugated, were from Invitrogen: goat anti-rabbit 350 A-21068, goat anti-mouse 555 A-32727, goat anti-chicken IgY 647 A-21449, and goat anti-rat 647 A-21247.
(ii) WB.
Rabbit polyclonal anti-p-Stat1 701 #9171 was purchased from Cell Signaling. Stat1 no. 610186 was from BD. Rabbit polyclonal anti-p-Beclin-1 threonine 119 in human sequence (threonine 117 in mouse sequence) was from Abgent. The antibody against P62 (NBP1-48320) was obtained from Novus Bio. Anti-β-actin (Poly6221) was from BioLegend. Mouse monoclonal anti-CHMP4B (clone 13G12) was from Covalab. The antibody against CHMP2B was purchased from R&D Systems. Monoclonal antibodies recognizing ISG15 (clone F9), BECN-1 (clone E8), VPS4 (clone E8), and anti-VP16 (1-21, sc-7545) were from Santa Cruz Biotechnology.
Immunofluorescence microscopy. (i) Neuron cultures.
Cultures were fixed using 4% PFA in 0.1 M phosphate buffer (PB) for 10 min. Coverslips were washed three times with 0.1 M PB and incubated with 1% BSA and 1% Triton X-100 in 0.1 M PB for 1 h and then overnight with primary antibodies diluted in 1% BSA, 1% Triton X-100 in 0.1 M PB. The next day, coverslips were washed three times with 1% Triton X-100 in 0.1 M PB for 10 min each, and then coverslips were incubated with secondary antibodies diluted in 1% BSA, 1% Triton X-100 in 0.1 M PB for 2 h. Finally, coverslips were washed with 1% Triton X-100 in 0.1 M PB for 10 min and in 0.1 M PB for an additional 10 min. After the final wash, coverslips were mounted in FluorSave (Calbiochem). Coverslips were imaged using an automated AxioVision Observer Z1 (Zeiss) microscope. Random tile images were acquired for analysis, and images were analyzed using ZEN2012 or NIH Fiji software.
(ii) Immunohistochemistry.
Mice were euthanized at the time point indicated by approved methods and transcardially perfused with PBS. TG were harvested and fixed ex vivo with 4% formaldehyde (PFA; Fisher Scientific) in 0.1 M PB for 3 h. They were washed 3 times in 0.1 M PB and incubated in 15% sucrose overnight at 4°C and in 30% sucrose overnight at 4°C. Cryoprotected ganglia were embedded in Tissue-Tek OCT compound (Sakura). The tissue was sectioned using a Leica CM1860 cryostat into 15-μm transverse plane sections, which were mounted directly onto charged glass slides (Thermo Scientific) and allowed to dry for 2 h. TG sections were carefully rehydrated with 0.1 M PB (3 times) and incubated with 1% BSA and 1% Triton X-100 in 0.1 M PB for 1 h, and immunostaining was performed as described above. Tissue sections were mounted in FluorSave, a coverslip was applied, and images were acquired and analyzed. Slides were imaged using an automated AxioVision Observer Z1 (Zeiss) microscope or using a Zeiss LSM 880 with Airyscan. Images were acquired for analysis, and images were analyzed using ZEN2012 or NIH Fiji software.
RNA isolation and real-time qPCR.
RNA was isolated by TRIzol extraction (Thermo Fisher) according to the manufacturer’s instructions. RNA was treated with the DNA-free kit (Ambion), and cDNA was synthesized using the SuperScript III reverse transcriptase kit (Invitrogen) with oligo(dT) (Promega) for real-time quantitative PCR (RT-qPCR). SYBR Select master mix (Life Technologies) was used, and RT-qPCR was performed using a CFX96 Touch real-time PCR detection system.
Oligonucleotides were as follows: β-actin, Fw, AGT GTG ACG TTG ACA TCC GT, and Rv, TGC TAG GAG CCA GAG CAG TA; Isg15, Fw, TGA GCA TCC TGG TGA GGA ACG AAA, and Rv, AGC CAG AAC TGG TCT TCG TGA CTT; Vps4A, Fw, GAC AAC GTC AAC CCT CCA GA, and Rv, AGC ATG CTG GTA GAG ACG GA; Vps4B, Fw, GCC TTG TCT GTA GTA GGG GAC, and Rv, TTC CCA GCT TTG TCT TCC TGG; Chmp4B, Fw, GCC CGA AAC AGT CCC TCT AC, and Rv, TTC CTT CTT CTT GGC GGG TT; Chmp2B, Fw, AAG CAG CTT GTC CAC CTA CG, and Rv, TTG CAT TGT CTT TGC AGT GGT.
Statistical analysis.
Statistical analysis was performed using GraphPad Prism. For two group conditions, data were analyzed using unpaired t test. For multiple group conditions, two-way ANOVA followed by a Bonferroni posttest was performed.
ACKNOWLEDGMENTS
We are grateful to the Dartmouth College Center for Comparative Medicine and Research for excellent animal husbandry. We thank Ann Lavanway for help with the Zeiss LSM 880 with Airyscan. Jesse Mehrbach provided superb technical support.
This work was made possible by funding from the Hitchcock Foundation of the Dartmouth Hitchcock Medical Center (to J.R.C.) and from NEI R01EY 09083 and NIAID P01 AI098681 (to D.A.L.). Support and input from the BioMT COBRE (P20-GM113132) are also acknowledged.
Footnotes
Citation Cabrera JR, Manivanh R, North BJ, Leib DA. 2019. The ESCRT-related ATPase Vps4 is modulated by interferon during herpes simplex virus 1 infection. mBio 10:e02567-18. https://doi.org/10.1128/mBio.02567-18.
Contributor Information
Terence S. Dermody, University of Pittsburgh School of Medicine.
Rozanne M. Sandri-Goldin, University of California, Irvine.
REFERENCES
- 1.Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed). 2013. Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA. [Google Scholar]
- 2.Roizman B, Whitley RJ. 2013. An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol 67:355–374. doi: 10.1146/annurev-micro-092412-155654. [DOI] [PubMed] [Google Scholar]
- 3.Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964–973. doi: 10.1001/jama.296.8.964. [DOI] [PubMed] [Google Scholar]
- 4.Whitley RJ, Roizman B. 2001. Herpes simplex virus infections. Lancet 357:1513–1518. doi: 10.1016/S0140-6736(00)04638-9. [DOI] [PubMed] [Google Scholar]
- 5.Itzhaki RF. 2014. Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virus. Front Aging Neurosci 6:202. doi: 10.3389/fnagi.2014.00202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med 189:663–672. doi: 10.1084/jem.189.4.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Orvedahl A, Alexander D, Tallóczy Z, Sun Q, Wei Y, Zhang W, Burns D, Leib DA, Levine B. 2007. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1:23–35. doi: 10.1016/j.chom.2006.12.001. [DOI] [PubMed] [Google Scholar]
- 8.Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. 2012. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 12:334–345. doi: 10.1016/j.chom.2012.07.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rosato PC, Leib DA. 2015. Neuronal interferon signaling is required for protection against herpes simplex virus replication and pathogenesis. PLoS Pathog 11:e1005028. doi: 10.1371/journal.ppat.1005028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ivashkiv LB, Donlin LT. 2014. Regulation of type I interferon responses. Nat Rev Immunol 14:36–49. doi: 10.1038/nri3581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Schneider WM, Chevillotte MD, Rice CM. 2014. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32:513–545. doi: 10.1146/annurev-immunol-032713-120231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo‐San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen E‐L, Fimia GM, Fulda S, Gewirtz DA, Green DR, Hansen M, Harper JW, Jäättelä M, Johansen T, Juhasz G, Kimmelman AC, Kraft C, Ktistakis NT, Kumar S, Levine B, Lopez‐Otin C, Madeo F, Martens S, Martinez J, Melendez A, Mizushima N, Münz C, Murphy LO, Penninger JM, Piacentini M, Reggiori F, Rubinsztein DC, Ryan KM, Santambrogio L, Scorrano L, Simon AK, Simon H‐U, Simonsen A, Tavernarakis N, Tooze SA, Yoshimori T, Yuan J, Yue Z, Zhong Q, Kroemer G. 2017. Molecular definitions of autophagy and related processes. EMBO J 36:1811–1836. doi: 10.15252/embj.201796697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lamb CA, Yoshimori T, Tooze SA. 2013. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol 14:759–774. doi: 10.1038/nrm3696. [DOI] [PubMed] [Google Scholar]
- 14.Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, Füllgrabe J, Jackson A, Jimenez Sanchez M, Karabiyik C, Licitra F, Lopez Ramirez A, Pavel M, Puri C, Renna M, Ricketts T, Schlotawa L, Vicinanza M, Won H, Zhu Y, Skidmore J, Rubinsztein DC. 2017. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93:1015–1034. doi: 10.1016/j.neuron.2017.01.022. [DOI] [PubMed] [Google Scholar]
- 15.Schmeisser H, Bekisz J, Zoon KC. 2014. New function of type I IFN: induction of autophagy. J Interferon Cytokine Res 34:71–78. doi: 10.1089/jir.2013.0128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Deretic V, Saitoh T, Akira S. 2013. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 13:722–737. doi: 10.1038/nri3532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zalckvar E, Berissi H, Mizrachy L, Idelchuk Y, Koren I, Eisenstein M, Sabanay H, Pinkas-Kramarski R, Kimchi A. 2009. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep 10:285–292. doi: 10.1038/embor.2008.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lee Y-R, Yuan W-C, Ho H-C, Chen C-H, Shih H-M, Chen R-H. 2010. The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses. EMBO J 29:1748–1761. doi: 10.1038/emboj.2010.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schöneberg J, Lee I-H, Iwasa JH, Hurley JH. 2017. Reverse-topology membrane scission by the ESCRT proteins. Nat Rev Mol Cell Biol 18:5–17. doi: 10.1038/nrm.2016.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.McCullough J, Colf LA, Sundquist WI. 2013. Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem 82:663–692. doi: 10.1146/annurev-biochem-072909-101058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nara A, Mizushima N, Yamamoto A, Kabeya Y, Ohsumi Y, Yoshimori T. 2002. SKD1 AAA ATPase-dependent endosomal transport is involved in autolysosome formation. Cell Struct Funct 27:29–37. doi: 10.1247/csf.27.29. [DOI] [PubMed] [Google Scholar]
- 22.Rusten TE, Vaccari T, Lindmo K, Rodahl LMW, Nezis IP, Sem-Jacobsen C, Wendler F, Vincent J-P, Brech A, Bilder D, Stenmark H. 2007. ESCRTs and Fab1 regulate distinct steps of autophagy. Curr Biol 17:1817–1825. doi: 10.1016/j.cub.2007.09.032. [DOI] [PubMed] [Google Scholar]
- 23.Sundquist WI, Kräusslich HG. 2012. HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med 2:a006924. doi: 10.1101/cshperspect.a006924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Crump CM, Yates C, Minson T. 2007. Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4. J Virol 81:7380–7387. doi: 10.1128/JVI.00222-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pawliczek T, Crump CM. 2009. Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J Virol 83:11254–11264. doi: 10.1128/JVI.00574-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kharkwal H, Smith CG, Wilson DW. 2014. Blocking ESCRT-mediated envelopment inhibits microtubule-dependent trafficking of alphaherpesviruses in vitro. J Virol 88:14467–14478. doi: 10.1128/JVI.02777-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kharkwal H, Smith CG, Wilson DW. 2016. HSV capsid localization to ESCRT-VPS4 complexes in the presence and absence of the large tegument protein UL36p. J Virol 90:7257–7267. doi: 10.1128/JVI.00857-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Arii J, Watanabe M, Maeda F, Tokai-Nishizumi N, Chihara T, Miura M, Maruzuru Y, Koyanagi N, Kato A, Kawaguchi Y. 2018. ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity. Nat Commun 9:3379. doi: 10.1038/s41467-018-05889-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Katzenell S, Leib DA. 2016. Herpes simplex virus and interferon signaling induce novel autophagic clusters in sensory neurons. J Virol 90:4706–4719. doi: 10.1128/JVI.02908-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB. 2007. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol 17:1561–1567. doi: 10.1016/j.cub.2007.07.029. [DOI] [PubMed] [Google Scholar]
- 31.Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. 2004. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15:1101–1111. doi: 10.1091/mbc.e03-09-0704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kuma A, Mizushima N. 2008. Chromosomal mapping of the GFP-LC3 transgene in GFP-LC3 mice. Autophagy 4:61–62. doi: 10.4161/auto.4846. [DOI] [PubMed] [Google Scholar]
- 33.Felipe C, Gonzalez GG, Gallar J, Belmonte C. 1999. Quantification and immunocytochemical characteristics of trigeminal ganglion neurons projecting to the cornea: effect of corneal wounding. Eur J Pain 3:31–39. doi: 10.1016/S1090-3801(99)90186-6. [DOI] [PubMed] [Google Scholar]
- 34.Lopez C. 1975. Genetics of natural resistance to herpesvirus infections in mice. Nature 258:152–153. doi: 10.1038/258152a0. [DOI] [PubMed] [Google Scholar]
- 35.Halford WP, Balliet JW, Gebhardt BM. 2004. Re-evaluating natural resistance to herpes simplex virus type 1. J Virol 78:10086–10095. doi: 10.1128/JVI.78.18.10086-10095.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sokawa Y, Ando T, Ishihara Y. 1980. Induction of 2′,5′-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus. Infect Immun 28:719–723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Liu T, Tang Q, Hendricks RL. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 70:264–271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sinha S, Levine B. 2008. The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 27:S137–S148. doi: 10.1038/onc.2009.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Button RW, Luo S, Rubinsztein DC. 2015. Autophagic activity in neuronal cell death. Neurosci Bull 31:382–394. doi: 10.1007/s12264-015-1528-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, Chin L-S, Choi A, Chu CT, Chung J, Clark RSB, Clarke PGH, Clarke SG, Clave C, Cleveland JL, Codogno P, Colombo MI, Coto-Montes A, Cregg JM, Cuervo AM, Debnath J, Dennis PB, Dennis PA, Demarchi F, Deretic V, Devenish RJ, Di Sano F, Dice JF, Distelhorst CW, Dinesh-Kumar SP, et al. . 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151–175. doi: 10.4161/auto.5338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Katsuragi Y, Ichimura Y, Komatsu M. 2015. P62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J 282:4672–4678. doi: 10.1111/febs.13540. [DOI] [PubMed] [Google Scholar]
- 42.Knorr RL, Lipowsky R, Dimova R. 2015. Autophagosome closure requires membrane scission. Autophagy 11:2134–2137. doi: 10.1080/15548627.2015.1091552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Bishop N, Woodman P. 2000. ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs cholesterol trafficking. Mol Biol Cell 11:227–239. doi: 10.1091/mbc.11.1.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Scheuring S, Röhricht RA, Schöning-Burkhardt B, Beyer A, Müller S, Abts HF, Köhrer K. 2001. Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein trafficking. J Mol Biol 312:469–480. doi: 10.1006/jmbi.2001.4917. [DOI] [PubMed] [Google Scholar]
- 45.Strand SS, Vanheyningen TK, Leib DA. 2004. The virion host shutoff protein of herpes simplex virus type 1 has RNA degradation activity in primary neurons. J Virol 78:8400–8403. doi: 10.1128/JVI.78.15.8400-8403.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Cabrera JR, Charron AJ, Leib DA. 2018. Neuronal subtype determines herpes simplex virus 1 latency-associated-transcript promoter activity during latency. J Virol 92:e00430-18. doi: 10.1128/JVI.00430-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Pincetic A, Kuang Z, Seo EJ, Leis J. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol 84:4725–4736. doi: 10.1128/JVI.02478-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kuang Z, Seo EJ, Leis J. 2011. Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. J Virol 85:7153–7161. doi: 10.1128/JVI.02610-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Wollert T, Wunder C, Lippincott-Schwartz J, Hurley JH. 2009. Membrane scission by the ESCRT-III complex. Nature 458:172–177. doi: 10.1038/nature07836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Christ L, Raiborg C, Wenzel EM, Campsteijn C, Stenmark H. 2017. Cellular functions and molecular mechanisms of the ESCRT membrane-scission machinery. Trends Biochem Sci 42:42–56. doi: 10.1016/j.tibs.2016.08.016. [DOI] [PubMed] [Google Scholar]
- 51.Lenschow DJ. 2010. Antiviral properties of ISG15. Viruses 2:2154–2168. doi: 10.3390/v2102154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch K-P, Horak I, Virgin HW. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104:1371–1376. doi: 10.1073/pnas.0607038104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Durfee LA, Lyon N, Seo K, Huibregtse JM. 2010. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 38:722–732. doi: 10.1016/j.molcel.2010.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hermann M, Bogunovic D. 2017. ISG15: in sickness and in health. Trends Immunol 38:79–93. doi: 10.1016/j.it.2016.11.001. [DOI] [PubMed] [Google Scholar]
- 55.Ramana CV, Chatterjee-Kishore M, Nguyen H, Stark GR. 2000. Complex roles of Stat1 in regulating gene expression. Oncogene 19:2619–2627. doi: 10.1038/sj.onc.1203525. [DOI] [PubMed] [Google Scholar]
- 56.Meissl K, Macho-Maschler S, Müller M, Strobl B. 2017. The good and the bad faces of STAT1 in solid tumours. Cytokine 89:12–20. doi: 10.1016/j.cyto.2015.11.011. [DOI] [PubMed] [Google Scholar]
- 57.Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, Thiessen N, Griffith OL, He A, Marra M, Snyder M, Jones S. 2007. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 4:651–657. doi: 10.1038/nmeth1068. [DOI] [PubMed] [Google Scholar]
- 58.Yates A, Akanni W, Amode MR, Barrell D, Billis K, Carvalho-Silva D, Cummins C, Clapham P, Fitzgerald S, Gil L, Girón CG, Gordon L, Hourlier T, Hunt SE, Janacek SH, Johnson N, Juettemann T, Keenan S, Lavidas I, Martin FJ, Maurel T, McLaren W, Murphy DN, Nag R, Nuhn M, Parker A, Patricio M, Pignatelli M, Rahtz M, Riat HS, Sheppard D, Taylor K, Thormann A, Vullo A, Wilder SP, Zadissa A, Birney E, Harrow J, Muffato M, Perry E, Ruffier M, Spudich G, Trevanion SJ, Cunningham F, Aken BL, Zerbino DR, Flicek P. 2016. Ensembl 2016. Nucleic Acids Res 44:D710–D716. doi: 10.1093/nar/gkv1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH. 1994. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol 88:268–274. doi: 10.1111/j.1365-2141.1994.tb05017.x. [DOI] [PubMed] [Google Scholar]
- 60.Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher MA, Neuberg DS, Levine RL, Moriggl R, Müller M, Gray NS, Jamieson CHM, Weng AP, Staudt LM, Druker BJ, Look AT. 2013. TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discov 3:564–577. doi: 10.1158/2159-8290.CD-12-0504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Cao Z-H, Zheng Q-Y, Li G-Q, Hu X-B, Feng S-L, Xu G-L, Zhang K-Q. 2015. STAT1-mediated down-regulation of Bcl-2 expression is involved in IFN-γ/TNF-α-induced apoptosis in NIT-1 cells. PLoS One 10:e0120921. doi: 10.1371/journal.pone.0120921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Pereira RA, Tscharke DC, Simmons A. 1994. Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J Exp Med 180:841–850. doi: 10.1084/jem.180.3.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Dobson CB, Wozniak MA, Itzhaki RF. 2003. Do infectious agents play a role in dementia? Trends Microbiol 11:312–317. doi: 10.1016/S0966-842X(03)00146-X. [DOI] [PubMed] [Google Scholar]
- 64.O’Connell D, Liang C. 2016. Autophagy interaction with herpes simplex virus type-1 infection. Autophagy 12:451–459. doi: 10.1080/15548627.2016.1139262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Eimer WA, Kumar N, Shanmugam N, Breakefield XO, Tanzi RE, Moir RD. 2018. Alzheimer’s disease-associated β-amyloid is rapidly seeded by Herpesviridae to protect against brain infection. Neuron 99:56–63.e3. doi: 10.1016/j.neuron.2018.06.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, Morrison KE, Pall HS, Hardiman O, Collinge J, Shaw PJ, Fisher EC. 2006. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67:1074–1077. doi: 10.1212/01.wnl.0000231510.89311.8b. [DOI] [PubMed] [Google Scholar]
- 67.Holm IE, Englund E, Mackenzie IRA, Johannsen P, Isaacs AM. 2007. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol 66:884–891. doi: 10.1097/nen.0b013e3181567f02. [DOI] [PubMed] [Google Scholar]
- 68.Vernay A, Therreau L, Blot B, Risson V, Dirrig-Grosch S, Waegaert R, Lequeu T, Sellal F, Schaeffer L, Sadoul R, Loeffler J-P, René F. 2016. A transgenic mouse expressing CHMP2Bintron5mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia. Hum Mol Genet 25:3341–3360. doi: 10.1093/hmg/ddw182. [DOI] [PubMed] [Google Scholar]
- 69.Krasniak CS, Ahmad ST. 2016. The role of CHMP2BIntron5 in autophagy and frontotemporal dementia. Brain Res 1649:151–157. doi: 10.1016/j.brainres.2016.02.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Smith KO. 1964. Relationship between the envelope and the infectivity of herpes simplex virus. Exp Biol Med 115:814–816. doi: 10.3181/00379727-115-29045. [DOI] [PubMed] [Google Scholar]
- 71.Rader KA, Ackland-Berglund CE, Miller JK, Pepose JS, Leib DA. 1993. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J Gen Virol 74:1859–1869. doi: 10.1099/0022-1317-74-9-1859. [DOI] [PubMed] [Google Scholar]
- 72.National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed National Academies Press, Washington, DC. [Google Scholar]
- 73.Katzenell S, Cabrera JR, North BJ, Leib DA. 2017. Isolation, purification, and culture of primary murine sensory neurons. Methods Mol Biol 1656:229–251. doi: 10.1007/978-1-4939-7237-1_15. [DOI] [PMC free article] [PubMed] [Google Scholar]